![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 29, 18250-18259, July 17, 1998
From the Departments of The acid sphingomyelinase (ASM) gene,
which has been implicated in ceramide-mediated cell signaling and
atherogenesis, gives rise to both lysosomal SMase (L-SMase), which is
reportedly cation-independent, and secretory SMase (S-SMase), which is
fully or partially dependent on Zn2+ for enzymatic
activity. Herein we present evidence for a model to explain how a
single mRNA gives rise to two forms of SMase with different cellular
trafficking and apparent differences in Zn2+ dependence.
First, we show that both S-SMase and L-SMase, which contain several
highly conserved zinc-binding motifs, are directly activated by zinc.
In addition, SMase assayed from a lysosome-rich fraction of Chinese
hamster ovary cells was found to be partially zinc-dependent,
suggesting that intact lysosomes from these cells contain subsaturating
levels of Zn2+. Analysis of Asn-linked oligosaccharides and
of N-terminal amino acid sequence indicated that S-SMase arises by
trafficking through the Golgi secretory pathway, not by cellular
release of L-SMase during trafficking to lysosomes or after delivery to
lysosomes. Most importantly, when Zn2+-dependent S-SMase
was incubated with SMase-negative cells, the enzyme was internalized,
trafficked to lysosomes, and became zinc-independent. We conclude that
L-SMase is exposed to cellular Zn2+ during trafficking to
lysosomes, in lysosomes, and/or during cell homogenization. In
contrast, the pathway targeting S-SMase to secretion appears to be
relatively sequestered from cellular pools of Zn2+; thus
S-SMase requires exogeneous Zn2+ for full activity. This
model provides important information for understanding the enzymology
and regulation of L- and S-SMase and for exploring possible roles of
ASM gene products in cell signaling and atherogenesis.
The Cellular Trafficking and Zinc Dependence of Secretory and
Lysosomal Sphingomyelinase, Two Products of the Acid Sphingomyelinase
Gene
,
,

Anatomy & Cell Biology and

Medicine, Columbia University,
New York, New York 10032, ¶ Amgen, Boulder, Colorado 80301, the
Department of Human Genetics, Mount Sinai School
of Medicine, New York, New York 10029, and the ** Dorrance H. Hamilton Research Laboratories, Division of Endocrinology, Diabetes,
and Metabolic Diseases, Thomas Jefferson University,
Philadelphia, Pennsylvania 19107
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. Uhlig and E. Gulbins Sphingolipids in the Lungs Am. J. Respir. Crit. Care Med., December 1, 2008; 178(11): 1100 - 1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jin, F. Yi, F. Zhang, J. L. Poklis, and P.-L. Li Lysosomal Targeting and Trafficking of Acid Sphingomyelinase to Lipid Raft Platforms in Coronary Endothelial Cells Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 2056 - 2062. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Devlin, A. R. Leventhal, G. Kuriakose, E. H. Schuchman, K. J. Williams, and I. Tabas Acid Sphingomyelinase Promotes Lipoprotein Retention Within Early Atheromata and Accelerates Lesion Progression Arterioscler. Thromb. Vasc. Biol., October 1, 2008; 28(10): 1723 - 1730. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Argraves and W. S. Argraves HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects J. Lipid Res., November 1, 2007; 48(11): 2325 - 2333. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Zeidan and Y. A. Hannun Activation of Acid Sphingomyelinase by Protein Kinase C{delta}-mediated Phosphorylation J. Biol. Chem., April 13, 2007; 282(15): 11549 - 11561. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Doehner, A. C. Bunck, M. Rauchhaus, S. von Haehling, F. M. Brunkhorst, M. Cicoira, C. Tschope, P. Ponikowski, R. A. Claus, and S. D. Anker Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow Eur. Heart J., April 1, 2007; 28(7): 821 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Charruyer, S. Grazide, C. Bezombes, S. Muller, G. Laurent, and J.-P. Jaffrezou UV-C Light Induces Raft-associated Acid Sphingomyelinase and JNK Activation and Translocation Independently on a Nuclear Signal J. Biol. Chem., May 13, 2005; 280(19): 19196 - 19204. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Mintzer, K. C. Appell, A. Cole, A. Johns, R. Pagila, M. A. Polokoff, I. Tabas, R. M. Snider, and J. A. Meurer-Ogden A Novel High-Throughput Screening Format to Identify Inhibitors of Secreted Acid Sphingomyelinase J Biomol Screen, April 1, 2005; 10(3): 225 - 234. [Abstract] [PDF] |
||||
![]() |
M. Seto, M. Whitlow, M. A. McCarrick, S. Srinivasan, Y. Zhu, R. Pagila, R. Mintzer, D. Light, A. Johns, and J. A. Meurer-Ogden A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase Protein Sci., December 1, 2004; 13(12): 3172 - 3186. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bezombes, S. Grazide, C. Garret, C. Fabre, A. Quillet-Mary, S. Muller, J.-P. Jaffrezou, and G. Laurent Rituximab antiproliferative effect in B-lymphoma cells is associated with acid-sphingomyelinase activation in raft microdomains Blood, August 15, 2004; 104(4): 1166 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Flood, M. Gustafsson, R. E. Pitas, L. Arnaboldi, R. L. Walzem, and J. Boren Molecular Mechanism for Changes in Proteoglycan Binding on Compositional Changes of the Core and the Surface of Low-Density Lipoprotein-Containing Human Apolipoprotein B100 Arterioscler. Thromb. Vasc. Biol., March 1, 2004; 24(3): 564 - 570. [Abstract] [Full Text] |
||||
![]() |
H. Qiu, T. Edmunds, J. Baker-Malcolm, K. P. Karey, S. Estes, C. Schwarz, H. Hughes, and S. M. Van Patten Activation of Human Acid Sphingomyelinase through Modification or Deletion of C-terminal Cysteine J. Biol. Chem., August 29, 2003; 278(35): 32744 - 32752. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Drobnik, G. Liebisch, F.-X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, and G. Schmitz Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients J. Lipid Res., April 1, 2003; 44(4): 754 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Grassme, V. Jendrossek, J. Bock, A. Riehle, and E. Gulbins Ceramide-Rich Membrane Rafts Mediate CD40 Clustering J. Immunol., January 1, 2002; 168(1): 298 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. UEDA, S. M. R. CAMARGO, X. HONG, A. G. BASNAKIAN, P. D. WALKER, and S. V. SHAH Role of Ceramide Synthase in Oxidant Injury to Renal Tubular Epithelial Cells J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2384 - 2391. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Paris, Z. Fuks, A. Kang, P. Capodieci, G. Juan, D. Ehleiter, A. Haimovitz-Friedman, C. Cordon-Cardo, and R. Kolesnick Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice Science, July 13, 2001; 293(5528): 293 - 297. [Abstract] [Full Text] |
||||
![]() |
S. R. P. MIRANDA, X. HE, C. M. SIMONARO, S. GATT, A. DAGAN, R. J. DESNICK, and E. H. SCHUCHMAN Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology FASEB J, October 1, 2000; 14(13): 1988 - 1995. [Abstract] [Full Text] |
||||
![]() |
E. Gulbins, A. Jekle, K. Ferlinz, H. Grassme, and F. Lang Physiology of apoptosis Am J Physiol Renal Physiol, October 1, 2000; 279(4): F605 - F615. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marathe, S. R.P. Miranda, C. Devlin, A. Johns, G. Kuriakose, K. J. Williams, E. H. Schuchman, and I. Tabas Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function Hum. Mol. Genet., August 12, 2000; 9(13): 1967 - 1976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, et al. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis PNAS, July 5, 2000; (2000) 150098097. [Abstract] [Full Text] |
||||
![]() |
K. Bernardo, O. Krut, K. Wiegmann, D. Kreder, M. Micheli, R. Schafer, A. Sickman, W. E. Schmidt, J. M. Schroder, H. E. Meyer, et al. Purification and Characterization of a Magnesium-dependent Neutral Sphingomyelinase from Bovine Brain J. Biol. Chem., March 10, 2000; 275(11): 7641 - 7647. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Marathe, G. Kuriakose, K. J. Williams, and I. Tabas Sphingomyelinase, an Enzyme Implicated in Atherogenesis, Is Present in Atherosclerotic Lesions and Binds to Specific Components of the Subendothelial Extracellular Matrix Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2648 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kirschnek, F. Paris, M. Weller, H. Grassme, K. Ferlinz, A. Riehle, Z. Fuks, R. Kolesnick, and E. Gulbins CD95-mediated Apoptosis in Vivo Involves Acid Sphingomyelinase J. Biol. Chem., August 25, 2000; 275(35): 27316 - 27323. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Reagan Jr., M. L. Hubbert, and G. S. Shelness Posttranslational Regulation of Acid Sphingomyelinase in Niemann-Pick Type C1 Fibroblasts and Free Cholesterol-enriched Chinese Hamster Ovary Cells J. Biol. Chem., November 22, 2000; 275(48): 38104 - 38110. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Wong, B. Xie, N. Beatini, P. Phu, S. Marathe, A. Johns, P. W. Gold, E. Hirsch, K. J. Williams, J. Licinio, et al. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: A possible link between inflammatory cytokines and atherogenesis PNAS, July 18, 2000; 97(15): 8681 - 8686. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kleine, G. Liu, N. Leblanc, and R. L. Hebert Bradykinin stimulates ceramide production by activating specific BK-B1 receptor in rat small artery Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H175 - H183. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |